Other grades of this product :
| RGFP966 Basic information |
| Product Name: | RGFP966 | | Synonyms: | 2-Propenamide, N-(2-amino-4-fluorophenyl)-3-[1-[(2E)-3-phenyl-2-propen-1-yl]-1H-pyrazol-4-yl]-, (2E)-;RGFP966 (E)-N-(2-Amino-4-fluorophenyl)-3-[1-[(E)-3-phenylprop-2-enyl]pyrazol-4-yl]prop-2-enamide;(E)-N-(2-amino-4-fluorophenyl)-3-(1-cinnamyl-1H-pyrazol-4-yl)acrylamide;2-Propenamide (N-(2-amino-4-fluorophenyl)-3-[1-[(2E)-3-phenyl-2-propen-1-yl]-1H-pyrazol-4-yl];RGFP966 Racemate;CS-1872;(E,E)-N-(2-Amino-4-fluorophenyl)-3-(1-cinnamyl-1H-pyrazol-4-yl)acrylamide;(E,E)-RGFP966 | | CAS: | 1396841-57-8 | | MF: | C21H19FN4O | | MW: | 362.4 | | EINECS: | | Product Categories: | Inhibitors | | Mol File: | 1396841-57-8.mol |
| RGFP966 Chemical Properties |
| Boiling point | 630.4±55.0 °C(Predicted) | | density | 1.19±0.1 g/cm3(Predicted) | | storage temp. | 2-8°C | | form | powder | | pka | 11.58±0.70(Predicted) | | color | white to beige |
| RGFP966 Usage And Synthesis |
| Uses | RGFP966 is a histone deacetylase 3 (HDAC3) inhibitor. | | Biochem/physiol Actions | RGFP966 changes signal-specific primary auditory cortical plasticity. It is highly effective in cardiomyopathy-associated pathologies. |
| RGFP966 Preparation Products And Raw materials |
|
日本语
한국어
Français
Deutsch
España
Türkiye